Dr. John Michael Moriarty, MD

Dr. Moriarty practices at Santa Clarita Radiation Oncology - Radiation Oncology - HOPD in Santa Clarita, California.

Dr. Moriarty's NPI, 1609009125, was assigned on September 1, 2009. Dr. Moriarty graduated from University College of Dublin National Univ SOM in 2003. Dr. Moriarty holds California license A122867.

Dr. Moriarty's primary practice is Santa Clarita Radiation Oncology - Radiation Oncology - HOPD, at 27235 Tourney Rd, Santa Clarita, CA 91355.

Dr. Moriarty's primary practice is Santa Clarita Radiation Oncology - Radiation Oncology - HOPD in Santa Clarita, California. Dr. Moriarty is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Entertainment Industry Medical Group. Dmand AI also links Dr. Moriarty to 3 more hospitals, 3 group practices and clinics, 2 medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moriarty practices, 9 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Moriarty's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Moriarty is board certified in interventional radiology and diagnostic radiology by the American Board of Radiology. Dr. Moriarty is licensed in California.

CMS data shows 28,587 Medicare services from Dr. Moriarty across 17 procedure codes in 2024, for 487 Medicare patients. Medicare paid $98,899 for them.

CMS counts 487 Medicare patients who saw Dr. Moriarty in 2024. The largest group is 65 to 74, with 229 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moriarty's median patient age at 62, with 44% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Moriarty for performance year 2024, reported through an alternative payment model (APM). Dr. Moriarty accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Moriarty as offering telehealth.

Dmand AI links 33 papers to Dr. Moriarty, published from 2010 to 2025. 2020 was the busiest year, with 7. The most frequent topics are Ireland, Cattle and Tuberculosis, Bovine. Dr. Moriarty's most frequent co-authors are Justin P. McWilliams, MD, Ravi N. Srinivasa, MD and Stephen Thomas Kee, MD.

Dmand AI links Dr. Moriarty to 2 clinical trials. Conditions studied include Pulmonary Embolism and Embolism.

CMS Open Payments shows 450 general payments to Dr. Moriarty from 42 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. AngioDynamics, Inc. paid the most, $308,652. It also lists 9 research payments totaling $598,013 from 2016 to 2019.

Dmand AI lists 1 award for Dr. Moriarty, most recently CMS Stage 1 EHR in 2013.

Dr. Moriarty graduated from University College of Dublin National Univ SOM in 2003. Dr. Moriarty is a member of ACP, RSNA and SIR.

Dr. Moriarty is in network with 9 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.